PT - JOURNAL ARTICLE AU - Gastón Vergara-Hermosilla AU - Andrés Navas TI - Extension and implementation of a system modelling the COVID-19 pandemic in Chile AID - 10.1101/2020.06.21.20136606 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.21.20136606 4099 - http://medrxiv.org/content/early/2020/06/23/2020.06.21.20136606.short 4100 - http://medrxiv.org/content/early/2020/06/23/2020.06.21.20136606.full AB - We modelling the dynamics of the COVID-19 epidemic taking into account the role of the unreported cases. In a first section we extend the model recently introduced/ implemented by Liu, Magal, Seydi and Webb, by considering different transmission rates for the infectious and unreported states, and we couple three new states related to hospitalized and fatalities. In addition, we introduce an operator that incorporates the effects of mitigation measures at the different rates considered in the system. Finally, we implemented the extended model in the Chilean context by considering variable the transmission rates and the fraction of unreported cases, the latter through an argument that uses mortality rates. We conclude with several conclusions and lines of future research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupported by the European Union Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 765579.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IMB, Universite de BordeauxAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOfficial data of Covid-19 by the Government of Chile